Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

Emmanuelle Le RayService d’Hématologie, Hôpital Cochin, AP-HP, Paris, France; ;Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France; Correspondence[email protected]

Lisa BelinDepartment of Biostatistics, Institut Curie, Paris, France;

Corine PlancherDepartment of Biostatistics, Institut Curie, Paris, France;

Philippe AnractFaculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France; ;Service de chirurgie orthopédique, Hôpital Cochin, AP-HP, Paris, France;

Antoine BabinetFaculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France; ;Service de chirurgie orthopédique, Hôpital Cochin, AP-HP, Paris, France;

Valérie DumaineFaculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France; ;Service de chirurgie orthopédique, Hôpital Cochin, AP-HP, Paris, France;

Jérôme TamburiniService d’Hématologie, Hôpital Cochin, AP-HP, Paris, France; ;Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France; ;Institut Cochin, Département Développement Reproduction Cancer, CNRS UMR8104, INSERM U1016, Paris, France;

Bénédicte Deau FischerService d’Hématologie, Hôpital Cochin, AP-HP, Paris, France; ;Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France;

Lise WillemsService d’Hématologie, Hôpital Cochin, AP-HP, Paris, France; ;Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France;

Leonardo MagroService d’Hématologie, CHRU Lille, Lille, France;

Thierry FaconService d’Hématologie, CHRU Lille, Lille, France;

Xavier LeleuService d’hématologie, CHU de Poitiers, Poitiers, France;

Didier BouscaryService d’Hématologie, Hôpital Cochin, AP-HP, Paris, France; ;Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France; ;Institut Cochin, Département Développement Reproduction Cancer, CNRS UMR8104, INSERM U1016, Paris, France;

Youlia M. KirovaDepartment of Radiation Therapy, Institut Curie, Paris, France

show all

Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date